Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial.

ABSTRACT:

Importance

Ivermectin is widely prescribed as a potential treatment for COVID-19 despite uncertainty about its clinical benefit.

Objective

To determine whether ivermectin is an efficacious treatment for mild COVID-19.

Design, setting, and participants

Double-blind, randomized trial conducted at a single site in Cali, Colombia. Potential study participants were identified by simple random sampling from the state's health department electronic database of patients with symptomatic, laboratory-confirmed COVID-19 during the study period. A total of 476 adult patients with mild disease and symptoms for 7 days or fewer (at home or hospitalized) were enrolled between July 15 and November 30, 2020, and followed up through December 21, 2020.

Intervention

Patients were r

SUBMITTER: Lopez-Medina E 

PROVIDER: S-EPMC7934083 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature